Vaccine and Physical Activity in the Era of Covid-19 Pandemic

Vaccine and Physical Activity in the Era of Covid-19 Pandemic Publisher Pubmed

Ghram A^{1, 2} ; Moalla W³ ; Lavie CJ⁴

Show Affiliations

1. Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tehran, Tehran, Iran
2. Department of Cardiac Rehabilitation, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
3. LR19JS01 EM2S: Education, Motricite, Sport et Sante, High Institute of Sport and Physical Education of Sfax, University of Sfax, Tunisia
4. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, New Orleans, LA, United States

Source: Progress in Cardiovascular Diseases Published:2021

[No abstract available]

Related Docs

Experts (# of related papers)

Style	Citing Format
MLA	Ghram A, Moalla W, Lavie CJ. "Vaccine and Physical Activity in the Era of Covid-19 Pandemic." Progress in Cardiovascular Diseases, vol. 67, no. , 2021, pp. 33-34.
APA	Ghram A, Moalla W, Lavie CJ (2021). Vaccine and Physical Activity in the Era of Covid-19 Pandemic. Progress in Cardiovascular Diseases, 67(), 33-34.
Chicago	Ghram A, Moalla W, Lavie CJ. "Vaccine and Physical Activity in the Era of Covid-19 Pandemic." Progress in Cardiovascular Diseases 67, no. (2021): 33-34.
Harvard	Ghram A, Moalla W, Lavie CJ (2021) 'Vaccine and Physical Activity in the Era of Covid-19 Pandemic', Progress in Cardiovascular Diseases, 67(), pp. 33-34.
Vancouver	Ghram A, Moalla W, Lavie CJ. Vaccine and Physical Activity in the Era of Covid-19 Pandemic. Progress in Cardiovascular Diseases. 2021;67():33-34.
BibTex	@article{ author = {Ghram A and Moalla W and Lavie CJ}, title = {Vaccine and Physical Activity in the Era of Covid-19 Pandemic}, journal = {Progress in Cardiovascular Diseases}, volume = {67}, number = {}, pages = {33-34}, year = {2021} }
RIS	TY - JOUR AU - Ghram A AU - Moalla W AU - Lavie CJ TI - Vaccine and Physical Activity in the Era of Covid-19 Pandemic JO - Progress in Cardiovascular Diseases VL - 67 IS - SP - 33 EP - 34 PY - 2021 ER -